| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 507,179 | 389,777 | 466,184 | 2,576,145 | | Cost of Revenue | 382,089 | 437,031 | 481,820 | 3,192,807 | | | Gross Profit | 125,090 | (47,254) | (15,636) | (616,662) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 23,686 | 27,645 | 29,014 | (483,204) | | Non Recurring | 20,171 | (1,241) | (18,930) | 188,743 | | Others | 67,724 | 67,646 | 67,858 | 74,934 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 34,693 | (141,304) | (93,578) | (397,135) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 21,220 | 1,035 | 840 | 1,016 | | Earnings Before Interest And Taxes | 35,877 | (140,269) | (92,738) | (396,119) | | Interest Expense | 44,614 | 45,067 | 46,919 | 58,671 | | Income Before Tax | (8,737) | (185,336) | (139,657) | (454,790) | | Income Tax Expense | 9,532 | (81,644) | (33,876) | (14,733) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (18,269) | (103,692) | (105,781) | (440,057) | | | Non-recurring Events | | Discontinued Operations | 2,841 | 907,258 | (45,632) | 2,402 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (15,428) | 803,566 | (151,413) | (437,655) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($15,428) | $803,566 | ($151,413) | ($437,655) |
|
0.51% Nasdaq 
Income Statement
